Skip to content

Evaluation of the Performance and Safety of the Atoldys/ Lexilens Glasses Developed to Improve the Reading of Dyslexic Subjects

Evaluation of the Performance and Safety of the Atoldys/ Lexilens Glasses Developed to Improve the Reading of Dyslexic Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04586621
Enrollment
41
Registered
2020-10-14
Start date
2021-01-19
Completion date
2021-06-29
Last updated
2022-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslexia

Brief summary

The aim of this study is to evaluate the efficacy and safety of a new medical device (Atoldys/ Lexilens glasses) on the improvement of reading skills of young dyslexic subjects.

Detailed description

Dyslexia is defined as a specific learning disability that is characterized by reading difficulties, in the absence of intellectual disability, neurological or psychiatric disorder, uncorrected sensory disturbance (sight, hearing) or an educational deficiency. Dyslexia appears in the child from the earliest stages of learning in the form of a difficulty in mastering the learning of reading. This disorder is manifested by a generally hesitant reading, slowed down, full of errors, requiring a lot of effort for the child and may impact his reading comprehension. The dyslexia-related deficiency is of variable intensity depending on the individual; it may be accompanied by calculus disorders (dyscalculia), oral language (dysphasia), motor coordination (dyspraxia) or attention disorders with or without hyperactivity. In nearly 40% of cases, a child affected by Dys disorders presents several learning disorders. To date, the causes of dyslexia are not yet clearly established. The wide variety of symptoms and disorders associated with dyslexia does not facilitate the identification of precise neurobiological / psycho cognitive mechanisms. There are therefore several theories: phonological, visual, temporal, cerebellar or proprioceptive auditory processing. Recently, following work published in 2017, an anatomical cause based on Maxwell's spots could also be a cause of dyslexia. The aim of this study is to evaluate a new medical device (class I CE marked) to compensate this probable anatomical cause: the Atoldys/ Lexilens glasses

Interventions

DEVICEAtoldys/ Lexilens - SHAM

Atoldys/ Lexilens: glasses with specific light frequency SHAM: glasses with no frequency

DEVICESHAM- Atoldys/ Lexilens

SHAM: glasses with no frequency Atoldys/ Lexilens: glasses with specific light frequency

Sponsors

Slb Pharma
CollaboratorOTHER
ABEYE
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
8 Years to 13 Years
Healthy volunteers
Yes

Inclusion criteria

* Schooled in CM1, CM2 or 6ème, * French mother tongue, * For whom developmental dyslexia has been diagnosed by a health professional who specializes in this learning disorder, * With near vision, without optical correction, equivalent to P5 or better according to the Parinaud scale (distance: 30-40 cm), * Presenting an IQ ≥ 80 and ≤130 according to the WISC-V test performed by a psychologist, * For whom a written consent was obtained regarding his study participation.

Exclusion criteria

* With medical history or presenting a neurological pathology, * Presenting a developmental disorder (autism, ADHD, ...), * Presenting hearing disorders, * Presenting an astigmatism of more than one uncorrected diopter, * Presenting other visual disorders, * Any other condition that, in the opinion of health professionals, could impair its ability to complete the study or could pose a significant risk.

Design outcomes

Primary

MeasureTime frameDescription
Reading performance aloud of a text with french E.L.FE Test1 dayE.L.FE Test (=Evaluation de la Lecture en FluencE) - Monsieur Petit and Le Géant égoïste texts : percentile

Secondary

MeasureTime frameDescription
Reading performance aloud of isolated words with french BALE Test1 dayBALE test (=Batterie Analytique de Langage Ecrit): percentile
Security: incidence of Adverse Events1 dayBy questioning the child & the speech therapist - evaluation of adverse effects due to glasses (Yes/ No): headache, nausea, dizziness, fatigue and eye fatigue. According to patient questioning and clinical exam, the Adverse Event Table will be completed (description, dates, severity, imputability, action,...).
Security: device deficiencies1 dayBy questioning the speech therapist - evaluation of deficiencies due to glasses: the device deficienciesTable will be completed (description, relation with adverse effect, taken measures,...).
Child's satisfaction regarding reading fluency and comprehension1 dayChild interview with numeric scale (0-10) and yes/ no answer
Speech therapist's satisfaction regarding Securirty, Performance and Usability of glasses1 dayspeech therapist interview with 4 points - Likert scale (Very good, Good, Moderate, Bad)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026